Peijia Medical pockets HK$2.34bn from hot IPO

Peijia Medical bagged HK$2.34bn ($302m) from its IPO after winning huge support from institutional and retail investors, according to a source close to the deal.
The Chinese medical device manufacturer launched a virtual roadshow for its IPO on May 5. The issuer opted to market its float of 152.5m shares at a fixed price of HK$15.36 per share.
Huatai and Morgan Stanley were the sponsors, as well as the global co-ordinators, bookrunners and ...Already a subscriber? Login
Further reading
-
Supranationals & Agencies
Dollar market hot for SSAs across curve as CPPIB looks long
-
Supranationals & Agencies
Cades takes size with first ever SSA sterling social bond
-
Sub-Sovereigns
Brandenburg undersubscribed for 25 year deal as Land NRW hits screens
-
High Grade
Vonovia tests demand for long dated corporate debt